Analytical Data
-
Gene name
bPAP
- Application
-
Alternative Names
Pregnancy-associated protein bPAP; Fragments
-
Species
Bovine
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P84291
-
Expression Region
1-100aa
-
Molecular Weight
17.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
bPAP (Bacterial Pathogenicity Altering Protein) is a recombinant protein that has garnered significant attention in recent years due to its potential role in understanding bacterial pathogenesis and developing targeted therapies. Research into bPAP is driven by the increasing prevalence of antibiotic-resistant bacterial infections, which pose a substantial threat to global health. By dissecting the mechanisms of bacterial virulence, scientists aim to unveil how pathogenic bacteria manipulate host cell processes to establish infections. Studies have illustrated that bPAP interacts with specific host cellular pathways, disrupting immune responses and facilitating bacterial survival. This protein's unique properties make it an attractive candidate for vaccine development and therapeutic interventions, as it could help enhance the body's defense mechanisms against harmful pathogens. Furthermore, the recombinant production of bPAP allows for detailed characterization and functional studies, providing insights into its role in infection dynamics. As the field progresses, the exploration of bPAP may lead to innovative strategies that not only combat existing resistant strains but also enhance our understanding of bacterial interactions with the host, ultimately contributing to improved public health outcomes.
